Madhavbaug signs MoU with Parul University for research and training tie-up
MADHAVBAUG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.8 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Madhavbaug has signed an MoU dated October 9, 2026, with Parul Institute of Ayurved, Parul University, for academic collaboration, clinical research, product development, training, and knowledge exchange. Key areas include joint research on Ayurvedic formulations, clinical trials and validation, product and prototype development, student internships and faculty training, pharmacovigilance, and exploration of commercialization. The MoU is a broad framework with no immediate financial commitment; specific projects, funding, IP rights and commercial terms will be governed by separate project agreements.
Strategic research and academic partnership that could support long-term product pipeline and clinical credibility, but no immediate financial impact or revenue commitment.